Capital City Trust Co. FL Purchases 483 Shares of Colgate-Palmolive (NYSE:CL)

Capital City Trust Co. FL grew its position in Colgate-Palmolive (NYSE:CL) by 0.8% during the third quarter, Holdings Channel reports. The institutional investor owned 59,430 shares of the company’s stock after acquiring an additional 483 shares during the quarter. Colgate-Palmolive comprises 1.5% of Capital City Trust Co. FL’s investment portfolio, making the stock its 20th largest holding. Capital City Trust Co. FL’s holdings in Colgate-Palmolive were worth $6,169,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. purchased a new position in Colgate-Palmolive in the second quarter worth $25,000. Continuum Advisory LLC raised its stake in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares during the last quarter. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the third quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive in the third quarter worth about $53,000. Finally, Gradient Investments LLC increased its holdings in shares of Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after acquiring an additional 400 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on CL. Sanford C. Bernstein lifted their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research note on Tuesday, July 30th. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research report on Monday, October 28th. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Finally, Morgan Stanley increased their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $93.56 on Monday. The company has a fifty day moving average of $99.31 and a two-hundred day moving average of $98.54. Colgate-Palmolive has a fifty-two week low of $75.17 and a fifty-two week high of $109.30. The stock has a market capitalization of $76.44 billion, a PE ratio of 26.81, a P/E/G ratio of 3.34 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.14%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 16.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.